Johnson & Johnson Wins EU Approval to Buy Synthes

Johnson & Johnson Wins EU Approval to Buy Synthes

Tim Boyle/Bloomberg

J&J, the world’s second-largest seller of health products, in April 2011 offered to buy West Chester, Pennsylvania-based Synthes for 159 Swiss francs a share in cash and stock.